Insider Trading History of Alexandria Venture Investments, Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Alexandria Venture Investments, Llc since 2018. This trader's CIK number is 1722024. At the time of last reporting, Alexandria Venture Investments, Llc was the 10% Owner of Applied Therapeutics Inc.. (stock ticker symbol APLT). Also see all insider trading activities at Applied Therapeutics Inc..

Note that in the past Alexandria Venture Investments, LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Constellation Pharmaceuticals Inc (CNST) by Alexandria Venture Investments, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 CNST 66,667 $1,000,005 0 $0 0 $0

Yearly summary of insider trading at Karuna Therapeutics, Inc. (KRTX) by Alexandria Venture Investments, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 KRTX 30,000 $480,000 0 $0 0 $0

Yearly summary of insider trading at Applied Therapeutics Inc. (APLT) by Alexandria Venture Investments, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 APLT 0 $0 247,258 $572,203 0 $0
2021 APLT 43,478 $999,994 0 $0 0 $0

Yearly summary of insider trading at Liquidia Technologies Inc (LQDA) by Alexandria Venture Investments, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 LQDA 136,364 $1,500,004 0 $0 0 $0

Yearly summary of insider trading at Ideaya Biosciences, Inc. (IDYA) by Alexandria Venture Investments, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 IDYA 50,000 $500,000 0 $0 0 $0

Yearly summary of insider trading at Metacrine, Inc. (MTCR) by Alexandria Venture Investments, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 MTCR 38,461 $499,993 0 $0 0 $0


Insider trading activities at 6 companies by Alexandria Venture Investments, Llc:

1. Constellation Pharmaceuticals Inc (CNST)

2. Karuna Therapeutics, Inc. (KRTX)

3. Applied Therapeutics Inc. (APLT)

4. Liquidia Technologies Inc (LQDA)

5. Ideaya Biosciences, Inc. (IDYA)

6. Metacrine, Inc. (MTCR)

Table 1. Insider trading of Constellation Pharmaceuticals Inc (CNST) by Alexandria Venture Investments, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-23 CNST Buy 66,667 15.00 1,000,005

Table 2. Insider trading of Karuna Therapeutics, Inc. (KRTX) by Alexandria Venture Investments, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-07-02 KRTX Buy 30,000 16.00 480,000

Table 3. Insider trading of Applied Therapeutics Inc. (APLT) by Alexandria Venture Investments, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-03 APLT Sale 143,450 2.31 331,369
2023-11-02 APLT Sale 103,808 2.32 240,834
2021-02-17 APLT Buy 43,478 23.00 999,994

Table 4. Insider trading of Liquidia Technologies Inc (LQDA) by Alexandria Venture Investments, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-30 LQDA Buy 136,364 11.00 1,500,004

Table 5. Insider trading of Ideaya Biosciences, Inc. (IDYA) by Alexandria Venture Investments, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-28 IDYA Buy 50,000 10.00 500,000

Table 6. Insider trading of Metacrine, Inc. (MTCR) by Alexandria Venture Investments, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-09-18 MTCR Buy 38,461 13.00 499,993

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Alexandria Venture Investments, Llc (10% Owner of Applied Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.